Historical record - last NADAC effective date: 7/17/2024
Product Information
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.3980 per EA under NDC 11534018704. Its NADAC has been published 371 times since Jul 12, 2017.
FDA first approved this application on Oct 28, 2016. Its Orange Book therapeutic-equivalence code is AA.
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE
butalbital, acetaminophen and caffeineStrength
300; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534018704
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
ACETAMINOPHEN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA207118FDA Approved
10/28/2016
TE Code
AA
On Market Since
1/10/2017
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has been published 371 times since Jul 12, 2017, and over the history we have for it it has declined 82.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3980 per EA |
|---|---|
| All-time high | $2.3602 (Aug 16, 2017) |
| All-time low | $0.3871 (May 22, 2024) |
| Median price | $0.7915 |
| Average price | $1.2050 |
| Largest weekly change | +34.5% (Jun 19, 2024) |
| Weeks tracked | 371 |
| Tracking since | Jul 12, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-27.4%
5Y
-40.0%
All
-82.9%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 21% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, manufactured by Sunrise Pharmaceutical Inc., is $0.3980 per EA (NDC 11534018704), effective Aug 14, 2024.
How has the price of BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has declined 82.9%. It has been tracked across 371 weekly CMS publications since Jul 12, 2017.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
Since Jul 12, 2017, the NADAC for BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE has ranged from a low of $0.3871 (May 22, 2024) to a high of $2.3602 (Aug 16, 2017), with a median of $0.7915 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE, is $0.3161 per EA — about 21% below BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE.
Who manufactures BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE?
BUTALBITAL-ACETAMINOPHEN-CAFFEINE 50-300-40 MG CAPSULE (NDC 11534018704) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.